Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Mohan Somasundaran
Affiliation
University of Massachusetts Chan Medical School
ORCID
Career Start Year
1985
Papers
62
H Index
27
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36893269
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
2023
35045267
Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
J Virol
2022
37274537
Anti-SARS-CoV-2 Activity of Adamantanes In Vitro and in Animal Models of Infection.
COVID
2022
35891350
A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.
Viruses
2022
35290796
Quantitative structural analysis of influenza virus by cryo-electron tomography and convolutional neural networks.
Structure
2022
34293929
SARS-CoV-2 Initiates Programmed Cell Death in Platelets.
Circ Res
2021
33619959
Inhibiting HTLV-1 Protease: A Viable Antiviral Target.
ACS Chem Biol
2021
33495478
Unique structural solution from a V<sub>H</sub>3-30 antibody targeting the hemagglutinin stem of influenza A viruses.
Nat Commun
2021
30381484
Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
J Virol
2019
29093087
Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection.
J Virol
2018
29687407
Ultradeep single-molecule real-time sequencing of HIV envelope reveals complete compartmentalization of highly macrophage-tropic R5 proviral variants in brain and CXCR4-using variants in immune and peripheral tissues.
J Neurovirol
2018
29760455
Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.
Sci Rep
2018
29118121
HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
J Virol
2018
28452355
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
Nat Commun
2017
27104621
Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants.
PLoS One
2016
27733645
High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
J Virol
2016
25693029
Viremic relapse after HIV-1 remission in a perinatally infected child.
N Engl J Med
2015
26573574
Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission.
Retrovirology
2015
26416268
A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection.
J Immunol
2015
25914058
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.
Structure
2015
24429365
Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.
J Virol
2014
23685212
Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.
Structure
2013
22181350
First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.
ACS Chem Biol
2012
23151449
Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates.
Hum Vaccin Immunother
2012
22821539
Mass spectrometry tools for analysis of intermolecular interactions.
Methods Mol Biol
2012
21843318
Genotypic and functional properties of early infant HIV-1 envelopes.
Retrovirology
2011
20152150
Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.
Structure
2010
20886079
Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.
PLoS One
2010
20578491
Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART).
Southeast Asian J Trop Med Public Health
2010
19503790
Low-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR.
PLoS One
2009
18177249
Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.
J Infect Dis
2008
18614660
Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C.
J Clin Microbiol
2008
17492595
Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.
J Infect Dis
2007
17598142
Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.
Proteins
2007
15655773
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.
J Infect Dis
2005
16049331
Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus.
Am J Pathol
2005
15989462
Nuclear localization of HIV type 1 Vif isolated from a long-term asymptomatic individual and potential role in virus attenuation.
AIDS Res Hum Retroviruses
2005
15452268
Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.
J Virol
2004
12594286
Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.
J Immunol
2003
14647384
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Nature
2003
12036487
Enhanced culture method for detection of replication-competent virus in peripheral blood mononuclear cells of HIV type 1-infected individuals.
AIDS Res Hum Retroviruses
2002
12093916
Evidence for a cytopathogenicity determinant in HIV-1 Vpr.
Proc Natl Acad Sci U S A
2002
10659052
Attenuation of human immunodeficiency virus type 1 cytopathic effects by replacing a 424-bp region of envelope from a noncytopathic biological clone.
AIDS Res Hum Retroviruses
2000
10558933
Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort.
J Infect Dis
1999
9333151
In vitro characterization of adult primary human immunodeficiency virus type 1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels of viral replication.
J Infect Dis
1997
9207357
Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo.
J Infect Dis
1997
9232625
Detection and differentiation of Epstein-Barr virus strains by in situ polymerase chain reaction.
Mol Cell Probes
1997
8947293
In vitro characterization of HIV type 1 biological clones from asymptomatic and symptomatic pediatric patients.
AIDS Res Hum Retroviruses
1996
7658067
Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children.
J Infect Dis
1995
7888220
Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.
AIDS Res Hum Retroviruses
1994
1 - 50 of 62
Column Actions
Search
Recommended Authors
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year
2010
Number of shared co-authors
0
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year
2001
Number of shared co-authors
2
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year
2000
Number of shared co-authors
1
Maudi Killian
University of California San Francisco
Career Start Year
1999
Number of shared co-authors
0
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year
1997
Number of shared co-authors
3
Paul D Bieniasz
The Rockefeller University
Career Start Year
1993
Number of shared co-authors
1
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year
1993
Number of shared co-authors
1
Wei Shao
Inc., Frederick National Laboratory for Cancer Research
Career Start Year
1993
Number of shared co-authors
2
Vicente Planelles
University of Utah
Career Start Year
1991
Number of shared co-authors
2
Keith R Jerome
Fred Hutchinson Cancer Center
Career Start Year
1991
Number of shared co-authors
1
Pavel Sova
Altius Institute for Biomedical Sciences
Career Start Year
1990
Number of shared co-authors
0
Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1990
Number of shared co-authors
2
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year
1988
Number of shared co-authors
0
Steven G Deeks
University of California san francisco
Career Start Year
1988
Number of shared co-authors
6
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year
1987
Number of shared co-authors
0
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year
1987
Number of shared co-authors
3
Bruce D Walker
Ragon Institute of Mass General
Career Start Year
1987
Number of shared co-authors
1
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1985
Number of shared co-authors
0
Stephen Raffanti
Vanderbilt University Medical Center
Career Start Year
1983
Number of shared co-authors
0
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year
1981
Number of shared co-authors
0
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year
1979
Number of shared co-authors
2
Robert F Siliciano
Johns Hopkins University School of Medicine
Career Start Year
1978
Number of shared co-authors
2
John Guatelli
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year
1978
Number of shared co-authors
2
Jeffrey D Lifson
Frederick National Laboratory
Career Start Year
1977
Number of shared co-authors
2
Amalio Telenti
Vir Biotechnology Inc.
Career Start Year
1977
Number of shared co-authors
0
Robert F Garry
Tulane University School of Medicine
Career Start Year
1974
Number of shared co-authors
0
Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Career Start Year
1973
Number of shared co-authors
0
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year
1972
Number of shared co-authors
2
Eric Hunter
Center for Family Health Research Zambia
Career Start Year
1971
Number of shared co-authors
1
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year
1970
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Celia A Schiffer
University of Massachusetts Chan Medical School
Co-authored papers
13
Shivender M D Shandilya
University of Massachusetts Medical School
Co-authored papers
6
Hiroshi Matsuo
Frederick National Laboratory for Cancer Research
Co-authored papers
4
Manuel Garber
Co-authored papers
3
Reuben S Harris
University of Texas Health San Antonio
Co-authored papers
3
Markus-Frederik Bohn
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers
3
Michael A Carpenter
University of Minnesota
Co-authored papers
2
Shan Lu
Co-authored papers
2
Ming Li
Department of Cancer Research Institute, University of South Australia
Co-authored papers
2
Akbar Ali
University of Massachusetts Chan Medical School
Co-authored papers
2
Anurag Rathore
Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center
Co-authored papers
2
Jeffrey D Jensen
Co-authored papers
2
Karin M Green
Co-authored papers
2
Barbara Tabak
Co-authored papers
2
Shixia Wang
Co-authored papers
2
Kangkang Song
University of Massachusetts Chan Medical School
Co-authored papers
1
William L Brown
University of Minnesota
Co-authored papers
1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers
1
Derek J Hook
Institute for Therapeutics Discovery and Development, University of Minnesota
Co-authored papers
1
Jeremy Luban
Co-authored papers
1
Keisuke Shindo
Graduate School of Medicine, Kyoto University
Co-authored papers
1
Mary Munson
University of Massachusetts Chan Medical School
Co-authored papers
1
Maria L Zapp
Co-authored papers
1
Brett D Anderson
University of Minnesota
Co-authored papers
1
Jane E Freedman
Vanderbilt University Medical Center
Co-authored papers
1
Daniel A Harki
University of Minnesota
Co-authored papers
1
Daniel I S Rosenbloom
Merck & Co. Inc.
Co-authored papers
1
Michael Emerman
Fred Hutchinson Cancer Center
Co-authored papers
1
Michael R Green
Co-authored papers
1
Caroline M Mitchell
Co-authored papers
1
1 - 30